CRA Strengthens Life Sciences Practice with Zealey Hire
Event summary
- Charles River Associates (CRA) appointed Christopher Zealey as Vice President in its Life Sciences Practice on October 6, 2026.
- Zealey brings expertise in medical affairs strategy, clinical positioning, and scientific communication.
- He previously led client engagements at a life sciences and pharmaceutical consulting firm.
- CRA's Life Sciences Practice serves biotech, medical device, and pharmaceutical companies.
The big picture
CRA's appointment of Zealey underscores the growing strategic role of medical affairs in the life sciences sector. As clients face increasingly complex scientific and stakeholder engagement challenges, CRA is positioning itself to deliver integrated solutions. The hire reflects broader industry trends where data-driven strategies and stakeholder insights are critical for product launches and asset optimization.
What we're watching
- Strategic Positioning
- How Zealey's expertise will enhance CRA's ability to address complex medical affairs challenges for clients.
- Industry Growth
- Whether CRA can sustain its growth trajectory in the life sciences sector amid increasing competition.
- Client Demand
- The pace at which CRA can convert Zealey's experience into measurable client engagements and revenue.